Desvenlafaxine Succinate Tablet, Film Coated, Extended Release
Product Images NDC 68788-8556

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine Succinate (NDC 68788-8556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E104f9c6 757f 4126 9479 8d50db02fe66 01)

Chemical structure of desvenlafaxine succinate, showing the molecular arrangement including a substituted phenyl ring, a cyclohexanol moiety, and the succinate component with associated water of hydration.*

FDA Label Image

Image (E104f9c6 757f 4126 9479 8d50db02fe66 02)

A figure illustrating the impact of intrinsic factors such as renal impairment, hepatic impairment, and population characteristics on desvenlafaxine pharmacokinetics. It presents geometric mean ratios with 90% confidence intervals for Cmax and AUC, comparing mild to severe impairment stages and population subsets by gender and age, relative to reference values.*

FDA Label Image

Image (E104f9c6 757f 4126 9479 8d50db02fe66 03)

A pharmacokinetic chart illustrating the effect of CYP3A4 inhibitor Ketoconazole on Desvenlafaxine. The graph shows geometric mean ratios with 90% confidence intervals for Cmax and AUC, plotted relative to reference values. Cmax and AUC ratios are approximately 1.08 and 1.43, respectively.*

FDA Label Image

Image (E104f9c6 757f 4126 9479 8d50db02fe66 04)

Figure displaying the effects of Desvenlafaxine on the pharmacokinetics of other drugs, including Desipramine, Midazolam, Tamoxifen, and Aripiprazole. The graph shows geometric mean ratios with 90% confidence intervals for Cmax and AUC parameters across different Desvenlafaxine dosages, illustrating changes relative to reference values.*

FDA Label Image

Image (E104f9c6 757f 4126 9479 8d50db02fe66 05)

A line graph titled 'Estimated Proportion of Relapses vs. Number of Days since Randomization (Study 5).' The x-axis represents time to relapse in days, ranging from 0 to 200, while the y-axis shows the estimated proportion of patients with relapse in percentages, ranging from 0% to 50%. Two lines are plotted: a solid line for Desvenlafaxine extended-release tablets 50 mg showing a lower relapse proportion over time, and a dashed line for placebo showing a higher relapse proportion over time.*

FDA Label Image

Image (E104f9c6 757f 4126 9479 8d50db02fe66 06)

A Kaplan-Meier curve depicting the estimated proportion of patients with relapse (%) over time in days from randomization for Desvenlafaxine extended-release tablets and placebo groups. The solid line represents Desvenlafaxine, showing a lower relapse rate over time compared to the dashed line representing placebo.*

FDA Label Image

Desvenlafaxine Extended-release Tablets 100mg (E104f9c6 757f 4126 9479 8d50db02fe66 09)

The image shows a Desvenlafaxine Extended-Release film-coated tablet label for 100 mg strength by Preferred Pharmaceuticals Inc. The label states it is generic for Pristiq and contains 152 mg Desvenlafaxine Succinate equivalent to 100 mg Desvenlafaxine per tablet. The tablet is described as round, orange, and imprinted with LU 562. Additional information includes storage instructions, manufacturer Lupin Limited, and fields for lot, batch, and expiration dates. The label also features directions for use in English and Spanish with a yellow background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.